| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 63.37B | 61.86B | 52.31B | 40.68B | 34.40B | 36.54B |
| Gross Profit | 18.28B | 17.19B | 14.60B | 11.52B | 9.96B | 10.00B |
| EBITDA | 8.00B | 7.88B | 5.87B | 4.91B | 4.53B | 4.33B |
| Net Income | 3.26B | 3.00B | 2.07B | 1.70B | 1.45B | 751.28M |
Balance Sheet | ||||||
| Total Assets | 84.72B | 87.81B | 81.03B | 73.07B | 65.40B | 66.44B |
| Cash, Cash Equivalents and Short-Term Investments | 25.17B | 21.85B | 22.26B | 16.43B | 14.23B | 12.15B |
| Total Debt | 16.42B | 16.75B | 16.82B | 18.07B | 17.12B | 20.84B |
| Total Liabilities | 40.70B | 42.48B | 39.13B | 37.04B | 32.33B | 34.76B |
| Stockholders Equity | 43.77B | 45.08B | 41.58B | 36.04B | 33.07B | 31.68B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 266.38M | 8.54B | 1.73B | 5.77B | -1.11B |
| Operating Cash Flow | 0.00 | 3.27B | 9.54B | 2.54B | 6.32B | -553.06M |
| Investing Cash Flow | 0.00 | -3.40B | -2.41B | -766.05M | -11.93M | -658.49M |
| Financing Cash Flow | 0.00 | -1.18B | -2.20B | -95.90M | -4.53B | 2.68B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥99.47B | 48.30 | 5.02% | 3.23% | -10.00% | -51.92% | |
79 Outperform | ¥47.15B | 8.79 | 8.36% | 2.39% | 18.14% | 83.08% | |
77 Outperform | ¥91.79B | 9.96 | 6.26% | 5.31% | 5.45% | 90.90% | |
75 Outperform | ¥68.69B | 16.94 | ― | 3.95% | -1.67% | -4.39% | |
74 Outperform | ¥95.58B | 14.29 | 9.39% | 1.68% | 9.27% | 69.52% | |
74 Outperform | ¥64.67B | 12.89 | ― | 2.54% | 2.00% | 39.80% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |